The use of Thymaline to correct immune status deviations in COVID-19 (rationale for the use of drug and clinical case)

20206 citationsJournal Article

Authors

S. А. Lukyanov · Ministry of Health of the Russian Federation

Kuznik Bi · Academy of Innovation Management

Khavinson VKh · St. Petersburg Institute of Bioregulation and Gerontology

К. Г. Шаповалов · Ministry of Health of the Russian Federation

Y. N. Smolyakov · Academy of Innovation Management

П.П. Терешков · Academy of Innovation Management

Yu. K. Shapovalov

Abstract

Читинская государственная медицинская академия 2 Инновационная клиника «Академия здоровья», Чита 3 Санкт-Петербургский институт биорегуляции и геронтологии

Topics & Keywords

COVID-19 Clinical Research Studies Long-Term Effects of COVID-19 Tryptophan and brain disorders

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Vrach

Volume 31, Issue 8, pp. 74-82

DOI: 10.29296/25877305-2020-08-12

Field-Weighted Citation Impact: 0.15